nafamostat has been researched along with benzothiazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Azouz, NP; Chung, DH; Craik, CS; Damalanka, VC; Hoffmann, M; Janetka, JW; Karmakar, P; Klampfer, L; Klingler, AM; Lee, M; Lourenço, AL; Mahoney, M; Mayer Bridwell, AE; O'Donoghue, AJ; Pöhlmann, S; Pwee, D; Rothenberg, ME; Rothlauf, PW; Stallings, CL; Tartell, MA; Thompson, CE; Voss, J; Whelan, SPJ | 1 |
1 other study(ies) available for nafamostat and benzothiazole
Article | Year |
---|---|
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.
Topics: Animals; Benzamidines; Benzothiazoles; Cell Line; COVID-19; COVID-19 Drug Treatment; Drug Design; Epithelial Cells; Esters; Guanidines; Humans; Lung; Mice; Middle East Respiratory Syndrome Coronavirus; Oligopeptides; SARS-CoV-2; Serine Endopeptidases; Small Molecule Libraries; Substrate Specificity; Virus Internalization | 2021 |